Opioids Don't Ease Disability in Neuropathic Pain

This article originally appeared here.
Share this content:
Opioids Don't Ease Disability in Neuropathic Pain
Opioids Don't Ease Disability in Neuropathic Pain

MONDAY, Feb. 1, 2016 (HealthDay News) -- Taking prescription opioids doesn't improve movement or reduce disability for patients with neuropathic pain, according to a study published recently in Pain Medicine.

Geoff Bostick, Ph.D., an associate professor of physical therapy at the University of Alberta in Edmonton, Canada, and colleagues evaluated data for 789 patients with neuropathic pain. Some were prescribed opioids while others didn't receive the drugs.

At six- and 12-month follow-ups, patients who took the opioids didn't show greater improvements in movement and disability than those who did not take the drugs, the investigators found.

"Pain is very complex, and people experience pain at very different levels," Bostick said in a university new release. "Opioids can help people with severe pain be more comfortable, but if they are not also facilitating improved function, the impact of these medications on quality of life should be questioned."

Two authors disclosed financial ties to Pfizer, which contributed funding to the study.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

Congress Approves Bill Expanding Private Care for VA Patients

Congress Approves Bill Expanding Private Care for VA ...

New bill would open up access to private doctors for veterans

AAP Recommending Injectable Flu Shot for 2018-19 Flu Season

AAP Recommending Injectable Flu Shot for 2018-19 Flu ...

Children should receive injectable vaccine, which has been shown to be more consistently effective

Neurologists Identify New Type of Vertigo

Neurologists Identify New Type of Vertigo

Long-term prognosis favorable, with improvement of symptoms in more than half of patients